Viewing StudyNCT00433095



Ignite Creation Date: 2024-05-05 @ 5:20 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00433095
Status: COMPLETED
Last Update Posted: 2011-03-14
First Post: 2007-02-07

Brief Title: Vinorelbine Oral Plus Trastuzumab for 1st-line Treatment of HER2Neu Overexpressing Breast Cancer
Sponsor: Ludwig-Maximilians - University of Munich
Organization: Ludwig-Maximilians - University of Munich

Conditions & Keywords Data

Conditions:
Name
Carcinoma Breast Stage IV
Keywords:
Name View
breast cancer View
Navelbine View
Herceptin View
oral View